For debate: that Australia should consider changing to the bivalent vaccine
- PMID: 21058497
- DOI: 10.1071/sh09131
For debate: that Australia should consider changing to the bivalent vaccine
Comment in
-
Commentary on opinion pieces re Australian human papillomavirus vaccine policy.Sex Health. 2010 Sep;7(3):242-3. doi: 10.1071/sh10026. Sex Health. 2010. PMID: 21058498 No abstract available.
Comment on
-
For debate: that Australia should continue using the quadrivalent vaccine.Sex Health. 2010 Sep;7(3):235-7. doi: 10.1071/sh09129. Sex Health. 2010. PMID: 21058496 No abstract available.
Similar articles
-
Commentary on opinion pieces re Australian human papillomavirus vaccine policy.Sex Health. 2010 Sep;7(3):242-3. doi: 10.1071/sh10026. Sex Health. 2010. PMID: 21058498 No abstract available.
-
Cervical cancer vaccine development.Sex Health. 2010 Sep;7(3):230-4. doi: 10.1071/SH09132. Sex Health. 2010. PMID: 20719210 Review.
-
For debate: that Australia should continue using the quadrivalent vaccine.Sex Health. 2010 Sep;7(3):235-7. doi: 10.1071/sh09129. Sex Health. 2010. PMID: 21058496 No abstract available.
-
[The first vaccine for prevention of cervix cancer and other human papillomavirus related diseases gets a positive evaluation by the European Drug Authority].Kinderkrankenschwester. 2006 Sep;25(9):389-90. Kinderkrankenschwester. 2006. PMID: 17017592 German. No abstract available.
-
Genital human papillomavirus infections.Front Biosci (Landmark Ed). 2018 Mar 1;23(9):1587-1611. doi: 10.2741/4662. Front Biosci (Landmark Ed). 2018. PMID: 29293452 Review.
Cited by
-
The public health and the question of the "best vaccine".Vaccine. 2022 Jun 21;40(28):3813-3814. doi: 10.1016/j.vaccine.2022.05.044. Epub 2022 May 26. Vaccine. 2022. PMID: 35644671 Free PMC article. No abstract available.
-
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.BMJ. 2011 Sep 27;343:d5775. doi: 10.1136/bmj.d5775. BMJ. 2011. PMID: 21951758 Free PMC article.